Flash News Investment - - RECOMMENDATIONS -

We had rec­om­mended MCX in Vol­ume no. 34, Is­sue no. 1 (dated Oc­to­ber 18, 2017) when the scrip was trad­ing at Rs 1110. Our rec­om­men­da­tion was backed by healthy Q2FY18 per­for­mance and the launch of op­tions trad­ing. Many de­vel­op­ments took place dur­ing this quar­ter which au­gured well for the com­pany. Last month, the com­pany launched op­tions for trad­ing and it is fo­cus­ing to in­crease par­tic­i­pa­tion and launch more new suites of prod­ucts. The com­pany is ex­pect­ing 20-25 per cent uptick in vol­ume of traded op­tions in the next 2-3 years. It is also plan­ning to make en­try into cur­ren­cies. These fac­tors will boost growth of the com­pany and we urge in­vestors to HOLD the scrip.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.